ランキングに戻る

The Ensign Group, Inc. (ENSG)

NEUTRAL
HealthcareMedical Care FacilitiesUnited States

ファンダメンタル

68

株価

$178.44

時価総額

$10.57B

パート1 · 企業の価値

概要

The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The Skilled Services segment provides short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management; and standard services, such as room and board, special nutritional programs, social services, recreational activities, entertainment, and other services. The Standard Bearer segment leases post-acute care properties to healthcare operators. In addition, the company operates senior living units; and provides ancillary services consisting of digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory, and long-term care pharmacy and patient transportation to people in their homes or at long-term care facilities, as well as mobile diagnostics. The company operates healthcare facilities in Alabama, Alaska, Arizona, Colorado, Idaho, Iowa, Kansas, Oregon, Nebraska, Nevada, South Carolina, Tennessee, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.

No editorial profile for this company yet

Direct competitors

Who this company fights with for the same customers

No editorial profile for this company yet

No competitor list for this company yet.

貸借対照表と流動性

売上高

$5.46B

直近12か月(2026/6/30まで)

純利益

$379M

直近12か月(2026/6/30まで)

フリーキャッシュフロー

-

自己資本合計

$2.23B

負債合計

$3.23B

流動比率

1.21

利払い倍率

59.99

負債/EBITDA

4.25

一株当たり利益(EPS)

売上高と純利益

フリーキャッシュフロー

収益内訳

財務推移表

利益率の推移

負債の推移

負債の重さ

成長率グリッド

成長率 — 売上高

適正価値の推定

適正価値

適正価値

$154.78

現在株価

$178.44

安全マージン

-15.3%

適正価値レンジ

$100.60 - $208.95

推定方法

Analyst Target:$220.00
DCF:$93.59
PE-based:$139.36
Graham Growth:$202.81
EPV:$75.66
アナリスト・コンセンサス:強い買い (10B / 2H / 0S)
直近の決算サプライズ:+2.16%

バリュエーション指標

P/E レシオ

28.11

ROE

15.4%

P/B レシオ

4.28

P/FCF

-

粗利益率

20.3%

ROIC

7.6%

収益性レーダー

Value Creation (Economic Moat)

ROIC

7.6%

WACC

6.8%

ROIC − WACC

+0.8 pp

ROIC is roughly in line with the cost of capital — the company is barely covering its capital cost.

ファンダメンタル分析基準

合格(17)

  • EPS shows upward trend
  • EPS CAGR 8.64%
  • Price CAGR 24.07%
  • ROIC 7.6%
  • Debt/Equity ratio
  • Operating Margin 8.6%
  • Current Ratio
  • Interest Coverage
  • Debt/EBITDA
  • Return on Tangible Assets
  • Low reliance on intangibles
  • ROE 16.5%
  • Revenue Growth 5Y 16.1%
  • Analyst Consensus 83% Buy
  • Earnings Quality (OCF/NI) 1.61
  • Share Dilution 1.2%
  • Piotroski F-Score 5/9

不合格(7)

  • Gross Margin 20.3%
  • P/B Ratio 4.28
  • Price below Graham Number
  • DCF valuation (Overvalued)
  • Earnings Surprise avg 0.7%
  • PEG Ratio 2.02
  • Net Margin Trend 6.9% vs 7.0%

データなし(4)

  • P/FCF NaN
  • Dividend Payout NaN%
  • Positive Free Cash Flow
  • CapEx intensity

Piotroski F-スコア

5/9

まちまちのシグナル:一部の領域に注意が必要

score
criteria

利益の質

1.61

高品質:利益はキャッシュに裏付けられている

株式希薄化

1.2%

株式数は安定している

ガバナンス

経営陣

氏名役職年齢
Mr. Barry R. PortCEO & Chairman of the Board51
Mr. Spencer W. BurtonPresident & COO46
Ms. Suzanne D. Snapper CPACFO, Executive VP & Director51
Mr. Chad A. Keetch J.D.Chief Investment Officer, Executive VP & Secretary47
Ms. Beverly B. WittekindExecutive VP & General Counsel60
Kevin ReesePresident of Keystone Healthcare Inc-

監査リスク

7

取締役会リスク

5

報酬リスク

7

株主権利リスク

2

パート2 · 株価と買い時

この部分は企業に価値があるかを判断するものではありません。ファンダメンタルズに納得したうえで、いつ買うかを選ぶためのものです。内容:テクニカル分析、ポテンシャル、過去のドローダウン、ガンマエクスポージャー。

Latest News

Recent headlines for ENSG, sourced from Markets Gazette.

No recent news for ENSG.